Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Crossover Trial of Cannabidiol to Treat Severe Behavior Problems in Children With Autism

NCT04517799 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT04517799
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04517799 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Crossover Trial of Cannabidiol to Treat Severe Behavior Problems in Children With Autism
Lead sponsor
University of California, San Diego
Phase
Phase 2
Overall status
Active, not recruiting
Start date
June 1, 2020
Completion date
December 31, 2025
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism, autism spectrum disorder